Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
NCT Number: NCT05670756
The study will only involve identification of the listed allergies from the electronic medical record and investigation into the symptoms that prompted this allergy listing. The purpose is to evaluate demographics and prevalence of allergies in patients presenting for surgery, evaluate the medical decision making process behind allergy identification, and determine its potential impact on perioperative care. The participants will be asked to complete a survey in REDCap using an iPad during the visit.
Looking for future studies?
Notify MeUp to 21 year
All sexes
Observational
Columbus, Ohio, 43205, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Parents/guardians will complete a survey about when the medication allergy was identified and the exact symptomatology that resulted in determination of the allergy.
Time frame: Baseline
Cutaneous reactions (hives, urticarial, skin redness, rash) within 6 h of the dose or Anaphylaxis or anaphylactoid reaction within 6 h of the dose
Time frame: Baseline
Cutaneous reactions (rash, skin redness) longer than 6 h after the dose
Time frame: Baseline
Allergy listed in the medical record but instead: Recognized adverse effect of the medication, Family history of allergy, Based on medical history or other reasons, or Parents reported their child has no allergy
Nationwide Children's Hospital
Other
Preoperative Survey to Evaluate Patient Allergy List, Type of Response to Listed Medication, and Its Relevance to Perioperative Care
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03581604
Allergy Drug, Chemically-Induced Disorders
Oslo, Postbox 4950 Nydalen, Norway
View Trial DetailsNCT06065137
Allergic Reaction, Anaphylactic Reaction
Edegem, Antwerp, Belgium
View Trial DetailsNCT07703982
Allergic Reaction, Hypersensitivity
Birmingham, Alabama, United States
View Trial DetailsNCT06011603
Allergic Reaction, Hypersensitivity
Chicago, Illinois, United States
View Trial Details